BR112013030682A2 - ensaio e métodos de uso da lisil-oxidase-like 2 - Google Patents

ensaio e métodos de uso da lisil-oxidase-like 2

Info

Publication number
BR112013030682A2
BR112013030682A2 BR112013030682A BR112013030682A BR112013030682A2 BR 112013030682 A2 BR112013030682 A2 BR 112013030682A2 BR 112013030682 A BR112013030682 A BR 112013030682A BR 112013030682 A BR112013030682 A BR 112013030682A BR 112013030682 A2 BR112013030682 A2 BR 112013030682A2
Authority
BR
Brazil
Prior art keywords
test
methods
lysyl oxidase
lysyl
oxidase
Prior art date
Application number
BR112013030682A
Other languages
English (en)
Portuguese (pt)
Inventor
Jason Chien
Jeffrey D Bornstein
Joanne I Adamkewicz
Lixin Shao
Susan K Lyman
Victoria Smith
Xiaoming Li
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013030682(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of BR112013030682A2 publication Critical patent/BR112013030682A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
BR112013030682A 2011-06-01 2012-06-01 ensaio e métodos de uso da lisil-oxidase-like 2 BR112013030682A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21
PCT/US2012/040585 WO2012167181A1 (en) 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112013030682A2 true BR112013030682A2 (pt) 2016-12-06

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013030682A BR112013030682A2 (pt) 2011-06-01 2012-06-01 ensaio e métodos de uso da lisil-oxidase-like 2

Country Status (25)

Country Link
US (3) US20140206017A1 (enExample)
EP (1) EP2714744A1 (enExample)
JP (3) JP2014523521A (enExample)
KR (1) KR20140048156A (enExample)
CN (1) CN103946241A (enExample)
AP (1) AP2013007285A0 (enExample)
AR (1) AR086657A1 (enExample)
AU (2) AU2012261883A1 (enExample)
BR (1) BR112013030682A2 (enExample)
CA (1) CA2837534A1 (enExample)
CL (1) CL2013003445A1 (enExample)
CO (1) CO6940375A2 (enExample)
CR (1) CR20130657A (enExample)
EA (1) EA201391627A1 (enExample)
EC (1) ECSP13013092A (enExample)
IL (1) IL229631A0 (enExample)
MA (1) MA35212B1 (enExample)
MD (1) MD20130098A2 (enExample)
MX (1) MX2013013905A (enExample)
PE (1) PE20141450A1 (enExample)
PH (1) PH12013502490A1 (enExample)
TW (1) TW201319572A (enExample)
UY (1) UY34115A (enExample)
WO (1) WO2012167181A1 (enExample)
ZA (1) ZA201308812B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) * 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
CA2771702A1 (en) 2009-08-21 2011-02-24 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and loxl2
BR112012019693A2 (pt) 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
WO2014070939A1 (en) * 2012-10-30 2014-05-08 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
EA201692202A1 (ru) 2014-06-11 2017-06-30 Джилид Сайэнс, Инк. Способы лечения сердечно-сосудистых заболеваний
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
JP2019510752A (ja) 2016-03-04 2019-04-18 ギリアード サイエンシーズ, インコーポレイテッド オートタキシン阻害剤の組成物及び合剤
JP2019513737A (ja) 2016-04-08 2019-05-30 ギリアード サイエンシーズ, インコーポレイテッド がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
RU2012110580A (ru) * 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. Способы скрининга in vivo
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
MX2013013905A (es) 2014-05-14
US20170269085A1 (en) 2017-09-21
AR086657A1 (es) 2014-01-15
KR20140048156A (ko) 2014-04-23
JP2016164578A (ja) 2016-09-08
IL229631A0 (en) 2014-01-30
AU2016244254A1 (en) 2016-11-03
MD20130098A2 (ro) 2014-06-30
AU2016244254B2 (en) 2018-10-18
JP2014523521A (ja) 2014-09-11
NZ618682A (en) 2016-04-29
UY34115A (es) 2013-01-03
WO2012167181A1 (en) 2012-12-06
CL2013003445A1 (es) 2014-07-25
AU2012261883A1 (en) 2013-05-02
AP2013007285A0 (en) 2013-11-30
ZA201308812B (en) 2014-08-27
JP2018049033A (ja) 2018-03-29
EA201391627A1 (ru) 2014-08-29
CR20130657A (es) 2014-05-16
US20120309020A1 (en) 2012-12-06
CO6940375A2 (es) 2014-05-09
PH12013502490A1 (en) 2014-01-20
MA35212B1 (fr) 2014-06-02
EP2714744A1 (en) 2014-04-09
CN103946241A (zh) 2014-07-23
TW201319572A (zh) 2013-05-16
US20140206017A1 (en) 2014-07-24
CA2837534A1 (en) 2012-12-06
PE20141450A1 (es) 2014-11-06
ECSP13013092A (es) 2014-08-29

Similar Documents

Publication Publication Date Title
FR21C1021I2 (fr) Compositions d'arni de pcsk9 et methodes d'utilisation associees
BR112012018329A2 (pt) agentes de coloração e métodos de uso destes
BR112013014119A2 (pt) novos moduladores e métodos de uso
BR112013007506A2 (pt) piridinonas/pirazinonas - métodos de criação e de uso
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI0910852A2 (pt) composições contendo lipídios e métodos de uso das mesmas
SMT201600228B (it) Sonda da focoemulsificazione bilanciata
CO6801741A2 (es) Derivados c4-monometil triterpenoides y sus métodos de uso
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BRPI1005292A2 (pt) composição de decapagem e uso da composição
ZA201308812B (en) Lysyl oxidase-like 2 assay and methods of use thereof
PT2585437E (pt) Compostos de tioacetato, composições e métodos de uso
BR112014028366A2 (pt) anticorpos anti-ly6e e imunoconjugados e métodos de uso
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
PT2424372T (pt) Composições antimicrobianas e métodos de uso relacionados
CO6862148A2 (es) Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas
BR112015002090A2 (pt) placa de laser e amplificador e método de uso
BR112013014231A2 (pt) composição de higiene pessoal e uso da composição de higiene pessoal
AT506816B1 (de) Vlf-prüfgenerator
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
BR112013008696A2 (pt) instrumento de redução de haste e métodos de redução de haste
BR112014009837A2 (pt) uso eficaz da levedura e extrato de levedura
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BR112015002331A2 (pt) revestimento termocrômico reversível e método de uso do mesmo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]